Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
US9675582B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | May 6, 2016 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | May 6, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An all-natural active ingredient herbal compositions and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin, derivatives of artemisinin, berberine, capsaicin and Tinospora Cordifolia. When formulated in a gel cap, the composition can consist of only artemisinin, berberine, capsaicin, and Tinospora cordifolia. A blended mixture and inert ingredients, such as selected excipient compounds, are mixed together with artemisinin, berberine, capsaicin, and Tinospora cordifolia and compressed to form a single pill, tablet, or capsule for the treatment of Zika virus. A tablet or pill for children is formulated to be chewable.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.